Cardiovascular Drugs and Therapy

ACE Cardiovascular Protection: EUROPA versus HOPE
pp. 179-180(2)
Authors: Boos C.J.; Dawes M.

Brain Natriuretic Peptide as a Surrogate Marker in Heart Failure Trials
pp. 181-182(2)
Author: Hildebrandt P.

Carvedilol Differentially Regulates Cytokine Production from Activated Human Peripheral Blood Mononuclear Cells
pp. 183-188(6)
Authors: Yang S-P.; Ho L-J.; Cheng S-M.; Hsu Y-L.; Tsao T-P.; Chang D-M.; Lai J-H.

Roles of Systemic Nitric Oxide Metabolites for Human Coronary Circulation
pp. 189-195(7)
Authors: Kato Y.; Kijima Y.; Kitakaze M.; Minamino T.; Matsu-ura Y.; Hashimura K.; Yasuda T.; Ueda T.; Mori I.; Hori M.

Effect of Long-Term Angiotensin II Type I Receptor Antagonism on Peripheral and Coronary Vasomotion
pp. 197-202(6)
Authors: Preumont N.; Unger P.; Goldman S.; Berkenboom G.

Improvement in Endothelial Progenitor Cells from Peripheral Blood by Ramipril Therapy in Patients with Stable Coronary Artery Disease
pp. 203-209(7)
Authors: Min T.Q.; Zhu C.J.; Xiang W.X.; Hui Z.J.; Peng S.Y.

Comparison of Cilostazol and Ticlopidine for One-Month Effectiveness and Safety after Elective Coronary Stenting
pp. 211-217(7)
Authors: Hashiguchi M.; Ohno K.; Nakazawa R.; Kishino S.; Mochizuki M.; Shiga T.

Methods of Assessing the Functional Status of Patients with Left Ventricular Systolic Dysfunction in Interventional Studies: Can Brain Natriuretic Peptide Measurement be Used as Surrogate for the Traditional Methods?
pp. 219-224(6)
Authors: Abdulla J.; Køber L.; Torp-Pedersen C.

High-Dose BoluS TiRofibAn and Sirolimus Eluting STEnt versus Abiciximab and Bare Metal Stent in Acute MYocardial Infarction (STRATEGY) Study—Protocol Design and Demography of the First 100 Patients
pp. 225-230(6)
Authors: Valgimigli M.; Percoco G.; Cicchitelli G.; Ferrari F.; Barbieri D.; Ansani L.; Guardigli G.; Parrinello G.; Malagutti P.; Soukhomovskaia O.; Bettini A.; Campo G.; Ferrari R.

Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin in Subclinical Atherosclerosis—The Rationale and Methodology of the METEOR Study
pp. 231-238(8)
Authors: Crouse III J.R.; Grobbee D.E.; O'Leary D.H.; Bots M.L.; Evans G.W.; Palmer M.K.; Riley W.A.; Raichlen J.S.; on behalf of the METEOR Study Group

Combined Treatment with Tranexamic Acid and Oral Contraceptive Pill Causes Coronary Ulcerated Plaque and Acute Myocardial Infarction
pp. 239-240(2)
Author: Iacobellis G.